Dual PRMT5 and MAT2A Inhibition Kills MTAP-Deficient Gliomas
In a groundbreaking advancement within the realm of neuro-oncology, researchers have unveiled a compelling synthetic lethality approach targeting MTAP homozygous-deficient gliomas by simultaneously inhibiting two...